UNIVERSITY HOSPITAL OF BROOKLYN
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $216K
- Transactions
- 71
- Companies
- 22
- Average per transaction
- $3,045
Who reported the payments
| Olympus America Inc. | $80,818 |
| Henry Schein, Inc. | $62,049 |
| Boehringer Ingelheim International GmbH | $19,075 |
| BD | $10,250 |
| AstraZeneca | $9,040 |
| AbbVie | $6,000 |
| Aurinia Pharma U.S., Inc. | $5,000 |
| Welch Allyn | $4,905 |
| National Marrow Donor Program | $4,400 |
| Immucor, Inc. | $4,155 |
| Abbott | $2,683 |
| Jazz Pharmaceuticals Inc. | $1,500 |
| ICU Medical Inc | $1,500 |
| Fisher Scientific Company L.L.C. | $1,276 |
| GE HealthCare | $1,163 |
| Davol Inc. | $750 |
| Smith+Nephew | $388 |
| Eli Lilly | $358 |
| Angiodynamics, Inc. | $335 |
| Cochlear Americas | $274 |
| Sysmex America, Inc. | $217 |
| Siemens Medical Solutions USA, Inc. | $44 |